Skip to main content

Agilent Technologies stock price and financials

  • A · NYSE
  • Instruments
  • Life Sciences Tools & Services
  • S&P 500
$173.96+0.55%Close 13 Nov 2026 · Next results 23 Nov 2026
Market value
$48.72B
P/E
33.83
EV / EBITDA
26.93
Dividend yield
0.6%
Beta · 1 year
0.91
Return · 1 year
+14.8%
52-week range$108.35 — $182.99

Share price close 16 Nov 2026

−1.5%1 monthHigh $181.48Low $169.90
$165$170$175$180$18523 Oct29 Oct4 Nov10 Nov16 Nov
+54.8%6 monthsHigh $181.48Low $110.57
$100$120$140$160$180$200Q2 FY2026 report filed 1 Jun 2026Q3 FY2026 report filed 1 Sep 20264 Jun2 Jul30 Jul26 Aug23 Sep20 Oct16 Nov
+27.1%year to dateHigh $181.48Low $110.24
$100$120$140$160$180$200Q1 FY2026 report filed 3 Mar 2026Q2 FY2026 report filed 1 Jun 2026Q3 FY2026 report filed 1 Sep 202611 Feb30 Mar14 May1 Jul17 Aug1 Oct16 Nov
+17.8%1 yearHigh $181.48Low $110.24
$100$120$140$160$180$200Q4 FY2025 report filed 22 Dec 2025Q1 FY2026 report filed 3 Mar 2026Q2 FY2026 report filed 1 Jun 2026Q3 FY2026 report filed 1 Sep 2026Jan 26Mar 26Apr 26Jun 26Aug 26Sep 26Nov 26
+52.2%3 yearsHigh $181.48Low $99.29
$75$100$125$150$175$200Q4 FY2023 report filed 20 Dec 2023Q1 FY2024 report filed 5 Mar 2024Q2 FY2024 report filed 3 Jun 2024Q3 FY2024 report filed 30 Aug 2024Q4 FY2024 report filed 20 Dec 2024Q1 FY2025 report filed 3 Mar 2025Q2 FY2025 report filed 2 Jun 2025Q3 FY2025 report filed 29 Aug 2025Q4 FY2025 report filed 22 Dec 2025Q1 FY2026 report filed 3 Mar 2026Q2 FY2026 report filed 1 Jun 2026Q3 FY2026 report filed 1 Sep 2026Apr 24Sep 24Feb 25Aug 25Jan 26Jun 26Nov 26
+284%10 yearsHigh $181.48Low $44.03
$0$50$100$150$200Apr 18Sep 19Feb 21Jul 22Jan 24Jun 25Nov 26

Quarterly or annual report filed

In one paragraph

Agilent Technologies reported revenue of $6.95 billion for fiscal year 2025 (the twelve months to 31 Oct 2025), up 6.7% from fiscal 2024. Net income was $1.30 billion and diluted earnings per share $4.57.

In its latest reported quarter, the third quarter of fiscal 2026 (the three months to 31 Jul 2026), revenue was $1.88 billion, up 8.1% from a year earlier.

Figures from Agilent Technologies's annual and quarterly reports, compiled and checked by AapWire. Latest report filed 1 Sep 2026.

Against Health Care

Growth
Lower half
Revenue +5.4% a year over five years · 27th of 37
Profitability
Top quarter
Return on invested capital 15.3%, five-year average · 10th of 38
Balance sheet
Upper half
Net debt 1.3× EBITDA · 16th of 38
Valuation
Above the median
P/E 33.8 · 20th of 36

Among the sector's S&P 500 members with the figure; the longer the bar, the better placed. Debt and P/E rank lower first.

Revenue FY2025
$6.95B+6.7%
Net income
$1.30B+1.1%
Diluted EPS
$4.57+3.2%
Gross margin
52.4%−1.9 pts
Free cash flow
$1.15B−16.1%
Net debt
$1.75B−21.9%

Fiscal 2025 against fiscal 2024; bars show the last 10 fiscal years; net debt is borrowings and operating lease liabilities less cash and short-term investments at the year end.

Revenue and net income fiscal 2016–2025

  • Revenue
  • Net income
$0$2B$4B$6B$8BRevenue, FY16: $4.2BNet income, FY16: $462MFY16Revenue, FY17: $4.47BNet income, FY17: $684MFY17Revenue, FY18: $4.91BNet income, FY18: $316MFY18Revenue, FY19: $5.16BNet income, FY19: $1.07BFY19Revenue, FY20: $5.34BNet income, FY20: $719MFY20Revenue, FY21: $6.32BNet income, FY21: $1.21BFY21Revenue, FY22: $6.85BNet income, FY22: $1.25BFY22Revenue, FY23: $6.83BNet income, FY23: $1.24BFY23Revenue, FY24: $6.51BNet income, FY24: $1.29BFY24Revenue, FY25: $6.95BNet income, FY25: $1.3BFY25

Latest quarter · Q3 FY2026 to 31 Jul 2026, filed 1 Sep 2026 · Full results →

Revenue
$1.88B+8.1% on a year
Gross margin
55.5%+4.4 pts on a year
Operating income
$444.0M+23.3% on a year
Net income
$362.0M+7.7% on a year
Diluted EPS
$1.28+8.5% on a year
Free cash flow
$439.0M+69.5% on a year

Comparable companies All of Health Care →

Agilent Technologies beside the other S&P 500 members in Life Sciences Tools & Services, by market value.

Agilent Technologies and comparable companies
CompanyMarket valueDay1 yearRevenue growthNet marginP/E
Agilent TechnologiesA$48.72B+0.5%+14.8%+8.6%19.5%33.8
Danaher CorporationDHR$163.0B+0.4%+6.2%+5.5%16.9%37.6
IQVIAIQV$43.52B−2.2%+20.0%+8.8%8.1%31.2
IlluminaILMN$30.43B−4.2%+65.3%+5.8%19.7%34.0
Charles River LaboratoriesCRL$16.06B−0.8%+97.1%−1.2%1.0%399.6
Bio-TechneTECH—−0.1%+18.6%———
Mettler ToledoMTD—+0.5%+20.1%———

Market value and moves at the latest close. Revenue growth compares the last twelve months with the twelve before; net margin and P/E over the last twelve months; P/E is left blank where earnings are negative.

Margins fiscal 2016–2025

  • Gross
  • Operating
  • Net
0%20%40%60%52.4%21.3%18.8%FY16FY19FY22FY25

Agilent Technologies revenue by segment, product and region

Fiscal years, as the company cuts its revenue in its annual reports; the change on a year under each figure. A change is left out from a loss, from a sliver of revenue, or across a change in how the company reports.

By segment

Agilent Technologies revenue by segment, by fiscal year
RevenueFY 2022FY 2023FY 2024FY 2025
Agilent CrossLab$2.56B$2.66B+3.6%$2.75B+3.4%$2.91B+5.9%
Life Sciences and Diagnostics Markets$2.84B$2.78B−2.3%$2.47B−11.3%$2.73B+10.5%
Applied Markets$1.44B$1.40B−3.1%$1.30B−7.2%$1.31B+1.3%
Total revenue$6.85B$6.83B$6.51B$6.95B

By product

Agilent Technologies revenue by product, by fiscal year
RevenueFY 2021FY 2022FY 2023FY 2024FY 2025
Non-Instrumentation and Other$3.66B$3.94B+7.6%$4.09B+3.8%$4.16B+1.6%$4.52B+8.8%
Instrumentation$2.66B$2.91B+9.4%$2.74B−5.7%$2.35B−14.2%$2.43B+3.1%
Total revenue$6.32B$6.85B$6.83B$6.51B$6.95B

By region

Agilent Technologies revenue by region, by fiscal year
RevenueFY 2021FY 2022FY 2023FY 2024FY 2025
Americas$2.40B$2.68B+11.6%$2.73B+1.9%$2.57B−5.8%$2.81B+9.1%
Asia Pacific$2.23B$2.47B+10.8%$2.35B−4.9%$2.17B−7.7%$2.22B+2.4%
Europe$1.69B$1.70B+0.7%$1.75B+3.2%$1.77B+0.9%$1.92B+8.6%
Total revenue$6.32B$6.85B$6.83B$6.51B$6.95B

Financial statements

Fiscal years, the latest ending 31 Oct 2025. Amounts in USD. On a narrow screen the table opens on the latest year and scrolls back.

Income statement

Agilent Technologies income statement, annual
PeriodFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue$4.20B$4.47B$4.91B$5.16B$5.34B$6.32B$6.85B$6.83B$6.51B$6.95B
Revenue growth+4.1%+6.4%+9.9%+5.1%+3.4%+18.4%+8.4%−0.2%−4.7%+6.7%
Gross profit$2.20B$2.41B$2.68B$2.81B$2.84B$3.41B$3.72B$3.46B$3.54B$3.64B
Operating income$615.0M$807.0M$904.0M$941.0M$846.0M$1.35B$1.62B$1.35B$1.49B$1.48B
Net income$462.0M$684.0M$316.0M$1.07B$719.0M$1.21B$1.25B$1.24B$1.29B$1.30B
Diluted EPS$1.40$2.10$0.97$3.37$2.30$3.94$4.18$4.19$4.43$4.57
Gross margin52.3%53.9%54.5%54.3%53.1%53.9%54.4%50.7%54.3%52.4%
Operating margin14.6%18.0%18.4%18.2%15.8%21.3%23.6%19.8%22.9%21.3%
Net margin11.0%15.3%6.4%20.7%13.5%19.1%18.3%18.1%19.8%18.8%

Cash flow

Agilent Technologies cash flow, annual
PeriodFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Operating cash flow$793.0M$889.0M$1.09B$1.02B$921.0M$1.49B$1.31B$1.77B$1.75B$1.56B
Capital expenditure$139.0M$176.0M$177.0M$155.0M$119.0M$188.0M$291.0M$298.0M$378.0M$407.0M
Free cash flow$654.0M$713.0M$910.0M$866.0M$802.0M$1.30B$1.02B$1.47B$1.37B$1.15B

Balance sheet and shares

Agilent Technologies balance sheet and shares, annual
PeriodFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Cash and equivalents$2.29B$2.68B$2.25B$1.38B$1.44B$1.48B$1.05B$1.59B$1.33B$1.79B
Total debt$1.89B$2.00B$1.79B$2.40B$2.54B$2.91B$2.92B$2.90B$3.57B$3.54B
Shareholders' equity$4.24B$4.83B$4.57B$4.75B$4.87B$5.39B$5.30B$5.84B$5.90B$6.74B
Diluted shares329M326M325M318M312M307M300M296M291M285M
Dividends per share$0.46$0.53$0.60$0.66$0.72$0.78$0.84$0.90$0.94$0.99

Quarterly figures

The last eight fiscal quarters, the latest ending 31 Jul 2026. Year-on-year growth compares the same quarter of the previous fiscal year.

Agilent Technologies quarterly financial figures
PeriodQ4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Revenue$1.70B$1.68B$1.67B$1.74B$1.86B$1.80B$1.83B$1.88B
Revenue, year on year+0.8%+1.4%+6.0%+10.1%+9.4%+7.0%+10.0%+8.1%
Gross margin53.9%53.5%51.9%51.1%53.2%52.6%54.0%55.5%
Operating income$408.0M$376.0M$300.0M$360.0M$443.0M$353.0M$399.0M$444.0M
Net income$351.0M$318.0M$215.0M$336.0M$434.0M$305.0M$339.0M$362.0M
Diluted EPS$1.23$1.11$0.75$1.18$1.52$1.07$1.20$1.28
Free cash flow$388.0M$334.0M$107.0M$259.0M$452.0M$175.0M$201.0M$439.0M

Operating KPIs

The operating figures Agilent Technologies reports beside its statements, then its revenue by product, segment and region, latest period first. Each links to its full history.

Agilent Technologies operating KPIs
KPILatestPeriodChange on a yearRecent periods
Product revenue$1.3Bquarter to 31 Jul 2026up 8.4%
Non-Instrumentation and Other revenue$1.2Bquarter to 31 Jul 2026up 8.4%
Instrumentation revenue$643.0Mquarter to 31 Jul 2026up 7.3%
Services and Other revenue$545.0Mquarter to 31 Jul 2026up 7.3%
Agilent CrossLab revenue$786.0Mquarter to 31 Jul 2026up 5.6%
Life Sciences and Diagnostics Markets revenue$746.0Mquarter to 31 Jul 2026up 11.3%
Applied Markets revenue$346.0Mquarter to 31 Jul 2026up 6.8%
Rest Of World revenue$3.4Bfiscal year to 31 Oct 2025up 11.0%
United States revenue$2.3Bfiscal year to 31 Oct 2025up 4.3%
China revenue$1.2Bfiscal year to 31 Oct 2025up 0.6%
Americas revenue$761.0Mquarter to 31 Jul 2026up 11.4%
Asia Pacific revenue$613.0Mquarter to 31 Jul 2026up 8.9%
Europe revenue$504.0Mquarter to 31 Jul 2026up 2.4%

Method

Each period is read from the report the company filed and checked against accounting identities before it is shown; a figure that does not pass is left blank rather than estimated. Free cash flow is operating cash flow less capital expenditure. Fiscal years follow the company's own calendar. See data and methodology.

The same figures as plain text and JSON.

Questions

What was Agilent Technologies's revenue in fiscal 2025?

$6.95 billion for fiscal year 2025 (the twelve months to 31 Oct 2025), as reported in its annual report.

What was Agilent Technologies's net income in fiscal 2025?

$1.30 billion for fiscal year 2025 (the twelve months to 31 Oct 2025).

What were Agilent Technologies's diluted earnings per share in fiscal 2025?

$4.57 for fiscal year 2025 (the twelve months to 31 Oct 2025).

What is Agilent Technologies's gross margin?

52.4% for fiscal year 2025 (the twelve months to 31 Oct 2025): gross profit divided by revenue.

What is Agilent Technologies's operating margin?

21.3% for fiscal year 2025 (the twelve months to 31 Oct 2025): operating income divided by revenue.

How much free cash flow did Agilent Technologies generate in fiscal 2025?

$1.15 billion for fiscal year 2025 (the twelve months to 31 Oct 2025): operating cash flow less capital expenditure.

Where does Agilent Technologies's revenue come from?

In fiscal 2025, by segment: Agilent CrossLab $2.91B (42%), Life Sciences and Diagnostics Markets $2.73B (39%), Applied Markets $1.31B (19%), out of $6.95B in all, as stated in its annual report.

In the terminal

Twenty years of Agilent Technologies's figures, KPIs, guidance and a cash-flow valuation.

  • Every report line and operating figure, quarter by quarter
  • Guidance against what was delivered
  • Insider trades and institutional holders
  • Alerts on results, filings and price
See plans